Company profile
AdaptVac company profile
AdaptVac is a joint-venture between ExpreS2ion Biotech and University of Copenhagen spin-out NextGen Vaccines. The goal of the Joint Venture is to create a world class unit for the development of highly competitive vaccines and therapeutics against infectious diseases, cancer, and immunological disorders.
Business identity
- Website
- https://www.adaptvac.com/
- Contact email
- [email protected]
- Phone number
- +45 26394649
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $1K+
- Founded
- 2017-01-01
Headquarters
- Headquarters
- Hørsholm, Capital Region, Denmark
- Postal code
- 2970
- Country code
- DK
- Continent
- Europe